Organization
Chelsea and Westminster NHS Foundation Trust
7 clinical trials
Clinical trial
Efficacy of BIC/F/TAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context of 'Test and Treat'Status: Completed, Estimated PCD: 2023-07-30
Clinical trial
Switch From Stable cART Containing ABA/3TC or TAF/FTC Plus Dolutegravir or Bictegravir to TDF/3TC/Doravirine in People Living With HIV: Impact on Lipids, Body Composition, Insulin Sensitivity, Neuroendocrine Function and Inflammation MarkersStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Efficacy, Tolerability and Acceptability of the Single Table Regimen (STR) Biktarvy® by Trans People Living With HIV (TPLWH)Status: Terminated, Estimated PCD: 2023-05-11
Clinical trial
Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch (DORDOL)Status: Recruiting, Estimated PCD: 2026-11-30
Clinical trial
The Effect of Dolutegravir on Whole-body Insulin Sensitivity, Lipid and Endocrine Profile in Healthy VolunteersStatus: Completed, Estimated PCD: 2023-12-31
Clinical trial
The Effect of Biktarvy (B/F/TAF) on Whole-body Insulin Sensitivity, Lipid and Endocrine Profile in Healthy VolunteersStatus: Recruiting, Estimated PCD: 2023-10-30